TPI
AQST icon

Trust Point Inc’s Aquestive Therapeutics AQST Stock Holding History

Trust Point Inc’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31,048
Closed -$129K – 489
2026
Q1 		$129K Buy
31,048
+7,000
+29% +$28.4K 0.01% 514
2025
Q4 		$155K Buy
24,048
+1,595
+7% +$9.94K 0.01% 475
2025
Q3 		$126K Buy
+22,453
New +$97.1K 0.01% 476
2025
Q2 		– Sell
-23,396
Closed -$67.8K – 409
2025
Q1 		$67.8K Buy
23,396
+9,625
+70% +$29.1K 0.01% 456
2024
Q4 		$49K Hold
13,771
– – ﹤0.01% 559
2024
Q3 		$68.6K Hold
13,771
– – 0.01% 513
2024
Q2 		$35.8K Hold
13,771
– – ﹤0.01% 494
2024
Q1 		$58.7K Buy
13,771
+3,726
+37% +$12.4K ﹤0.01% 523
2023
Q4 		$20.3K Buy
+10,045
New +$17.8K ﹤0.01% 495

Other funds holding AQST

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
ACA
Adirondack Capital Advisors Syracuse, New York $186M AUM
CCM
Cox Capital Management Andover, Massachusetts $180M AUM 40.44% 1-Year Est. Return
LWA
Lineweaver Wealth Advisors Valley View, Ohio $845M AUM 20.71% 1-Year Est. Return
EC
Eleva Capital Paris, France $343M AUM
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
LF
LifeSteps Financial Claremont, California $215M AUM 27.52% 1-Year Est. Return

Trust Point Inc's AQST Position: Q2 2026 in Review

Trust Point Inc sold out of Aquestive Therapeutics (AQST) in Q2 2026, closing a stake of 31,048 shares — an estimated $129K sold.

Trust Point Inc first reported a position in AQST in Q4 2023 and held it in 9 quarters. The position peaked at $155K in Q4 2025. 11 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Trust Point Inc reported no remaining Aquestive Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Trust Point Inc sold 31,048 Aquestive Therapeutics shares in Q2 2026, an estimated $129K.
  • Trust Point Inc first reported a position in Aquestive Therapeutics in Q4 2023 and held it in 9 quarters.
  • Trust Point Inc's Aquestive Therapeutics position peaked at $155K in Q4 2025.
  • 11 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.